$4.4 Billion Gastrointestinal Endoscopic Market in the U.S.

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
$4.4 Billion Gastrointestinal Endoscopic Market in the U.S. and Europe Projected for 2020

VANCOUVER, B.C., Oct. 9, 2014 (GLOBE NEWSWIRE) -- via PRWEB - According to a new report by iData Research ( http://www.idataresearch.com ), the leading global authority in medical device market research, the U.S. and European gastrointestinal endoscopic market is expected to grow to over $4.4 Billion by 2020. This market is segmented into gastrointestinal (GI) endoscopes, capsule endoscopes, stenting devices, dilation devices, endoscopic retrograde cholangiopancreatography (ERCP) devices, biopsy forceps, polypectomy snares, hemostasis devices and enteral feeding devices. Market growth will primarily be driven by an increase in demand for gastrointestinal endoscopic procedures.

Gastrointestinal endoscopy is one of the most widely performed medical procedures in the world. It is projected that there will be over 75 million gastrointestinal endoscopic procedures performed in the U.S. and Europe combined by 2020. The majority of these procedures are colon cancer screenings, the removal of gastrointestinal tract abnormalities, as well as the placement and replacement of enteral feeding.

"Colonoscopy is the most common procedure used to screen for colorectal cancer. It efficiently facilitates the diagnosis and treatment of colon cancer at the same time," says Dr. Kamran Zamanian, CEO of iData. Recent positive publicity for virtual colonoscopy will act as a market driver, likely at the expense of conventional colonoscopy revenues. This rising demand for colorectal cancer screening is expected to drive the market for gastrointestinal endoscopes and instrumentation.

Other factors that will shape the U.S. and European gastrointestinal endoscopic market:

Reimbursement Cuts

Imaging reimbursement is expected to continue to decline in the U.S., limiting growth in procedure numbers. Additional reimbursement cuts to physicians in ambulatory centers and hospitals are expected to reduce low-paying procedures such as colonoscopies. In Europe, although great strides have been made to reimburse and promote colorectal screening, some markets remain suppressed by limited reimbursement policies, like Italy and Portugal.

Technological Innovation in the GI Endoscope Market

Technological advancements will continue to drive the U.S. and European gastrointestinal endoscope market. New generations of endoscopes will continue to progressively improve on visualization and detection technologies. This market is projected to exceed $1.7 billion by 2020.

Commoditization

The markets for stenting and dilation devices, biopsy forceps, polypectomy snares and fine aspiration needles are expected to experience an increase in commoditization and a lack of technological advancement. Products in these segments have few distinguishable features to set them apart from those of other companies. Competition will be focused on price.

Leading the U.S and European gastrointestinal endoscopic market is Olympus, who has been taking market share from another key competitor Boston Scientific, in the last few years. Other leading competitors driving this market include Pentax, Fujinon, Cook Medical, Kimberley-Clark/Vygon, Fresenius Kabi and Covidien.

For Further Information

The global series on the "Markets for Gastrointestinal Endoscopic Devices" covers 21 countries, including the U.S., Canada, Japan, India, China and 15 Countries in Europe. Full reports provide a comprehensive analysis, including procedure numbers, units sold, market value, forecasts, as well as detailed competitive market shares and analyses of major players' success strategies in each market and segment.

Receive a free synopsis of the U.S. and or European gastrointestinal endoscopic market report

About iData Research

iData Research ( http://www.idataresearch.com ) is an international market research and consulting group focused on providing market intelligence for medical device and pharmaceutical companies. iData covers research in: Diabetes Drugs, Diabetes Devices, Pharmaceuticals, Anesthesiology, Wound Management, Orthopedics, Cardiovascular, Ophthalmic, Endoscopy, Gynecology, Urology and more.

This article was originally distributed on PRWeb. For the original version including any supplementary images or video, visit http://www.prweb.com/releases/2014/10/prweb12232262.htm

iData Research Caroline Lau +1 604-266-6933 Ext: 215

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Arbor Realty Trust Faces Securities Fraud Allegations

Updated Category News Views 125

Securities Lawsuit Against Arbor Realty Trust Looms Well, here we go again. Another day, another securities lawsuit hitting the headlines. This time it's Arbor Realty Trust (NYSE: ABR) getting caught in the crossfire, accused of pulling the wool over investors' eyes. Seems like 'truth in advertising' is just part of the PR playbook for some big shots. Understanding the...

Continue Reading
PawnMate Boosts Inventory Efficiency for Pawnshops

Updated Category News Views 213

RFID Technology: Breathing New Life into Pawnshops Let's get things rolling with the cold, hard truth that pawnshops aren't exactly what most folks expect when it comes to cutting-edge technology. But times are a-changin', and PawnMate’s RFID Inventory Module is the latest twist in this industry storyline. It's like swapping out a rusty toolbox for a brand-new set of...

Continue Reading
Epic Legal Battle Yields $63M Verdict Against Chevron

Updated Category News Views 396

A David vs. Goliath Showdown in Court How's this for a courtroom drama? Picture eight lawyers taking on Chevron over a toxic pit buried beneath an unsuspecting family's home. These folks at Ernst Law Group and Trial Lawyers for Justice tackled Union Oil (now Chevron) and bagged a staggering $63 million for their client. This ain't your run-of-the-mill legal squabble; it's...

Continue Reading
Tenax Class Action: Investors Alley Fight for Redress

Updated Category News Views 192

Tenax Therapeutics in Hot Water Over Drug Trial Results Amidst the ever-unpredictable tides of the pharmaceutical industry, here comes a doozy – Tenax Therapeutics, Inc. is neck-deep in a shareholder lawsuit. If you tossed some money at NASDAQ:TENX anytime between November 13, 2023, and August 7, 2026, you might be feeling the sting of regret, and rightly so. What Went...

Continue Reading
LA Auto Show 2026: Thrills, Games, and Cars Galore

Updated Category News Views 92

A Family Day Like No Other at the LA Auto Show Kicking into gear this November, the 2026 Los Angeles Auto Show puts the pedal to the metal for families seeking a full day of fun without breaking the bank. We're talking about 10 solid days where auto-mania meshes with interactive experiences, all nestled in the Los Angeles Convention Center. Whether you're a gearhead or a...

Continue Reading
Kinross Gold Fraud Lawsuit: What Shareholders Need to Know

Updated Category News Views 64

Kinross Gold's Legal Quagmire There's a fresh storm brewing for Kinross Gold Corporation (NYSE: KGC), and it ain't the kind investors enjoy riding. You see, the company is up to its neck in a class action lawsuit, courtesy of Schall, Brown & Schwartz LLP—a big-name shareholder rights litigation outfit. The gripe? Alleged securities fraud, violating §§10(b) and 20(a)...

Continue Reading
Bona's 2027 Floorcast Finds Wood and Trust Still Win

Updated Category News Views 89

Floors are turning into a long-game purchase again Gray flooring may be limping toward the exit, but the more important signal in Bona's 2027 Floorcast is that homeowners are thinking less like bargain hunters and more like custodians of an expensive asset. That is a useful read for anybody watching the home-improvement and maintenance landscape. People do not replace a...

Continue Reading
MassMedia's Two PRSA Wins Put Campaign Strategy in Focus

Updated Category News Views 0

A pair of trophies is nice; the underlying work matters more. MassMedia picked up two honors at the 2026 PRSA Las Vegas Valley Chapter Pinnacle Awards, presented October 28 at Siena Golf Club. One was a Pinnacle Award in Community Relations for its Safe Teen Driving work with Sam & Ash Injury Law. The other was an Award of Excellence in Reputation and Brand Management for...

Continue Reading
Rakuten Medical Fires Up Phase 1 Trial for RM-0256 Therapy

Updated Category News Views 272

Taking Aim at Refractory Tumors in Japan Get this—Rakuten Medical is stepping into the ring with their new cancer-busting tactic, RM-0256 photoimmunotherapy, right in Japan. We're talking about a Phase 1 trial that'll throw a new kind of punch at solid tumors, specifically targeting troublesome skin cancers that don’t seem to play nice with current treatments. Now,...

Continue Reading
Holiday Grease Advice Shows Utility Work Up Close Today

Updated Category News Views 0

Butter and pan drippings are mundane right until they become a backed-up kitchen line on a crowded holiday afternoon. New Jersey American Water's Nov. 17, 2026 reminder is not glamorous utility news, and frankly it is not trying to be. It is a practical warning: fats, oils and grease can cool, harden and accumulate in household pipes and farther along the wastewater...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovation and Growth: The Future of CODiE Awards 2025

Updated Category News Views 206

The Exciting Future of the CODiE Awards The CODiE Awards, a prestigious program that shines a light on excellence in technology, is stepping into a thrilling new era. With a legacy spanning nearly 40 years, the CODiE Awards are set to expand in 2025, showcasing a wider array of groundbreaking technologies that are reshaping multiple industries, including tech products,...

Continue Reading
aTyr Pharma's Optimistic Trial Data Strengthens Market Position

Updated Category News Views 288

aTyr Pharma's Positive Trial Results Highlight Drug Potential aTyr Pharma (NASDAQ: ATYR) recently reaffirmed its Buy rating and set a price target of $22.00 amid encouraging trial data for its innovative treatment efzofitimod, targeting pulmonary sarcoidosis. This re-evaluation followed the release of a detailed post hoc analysis from its Phase 1/2a clinical trial, which...

Continue Reading
Precision Sapphire Wafers: Redefining Optical Coating Standards

Updated Category News Views 236

Introducing Ultra-Flat Sapphire Wafers for Optical Coating Meller Optics, Inc. has revolutionized the optical industry by launching a full line of optical-grade sapphire wafers. These wafers are fabricated through a proprietary process that ensures extreme flatness, a crucial requirement for high-quality optical applications. Exceptional Specifications of Sapphire Wafers...

Continue Reading
FHLB Dallas and First Security Bank Grant $30K to Local Charity

Updated Category News Views 138

FHLB Dallas and First Security Bank Collaborate to Aid Conway Ministry Center In a significant initiative aimed at community support, representatives from the Federal Home Loan Bank of Dallas (FHLB Dallas) and First Security Bank have come together to award an impressive $30,000 grant to the Conway Ministry Center. This generous funding is designated to enhance shelter...

Continue Reading
Exploring the Future of the Content Management System Market

Updated Category News Views 187

Growing Demand in the Content Management System Market The Content Management System market is witnessing a remarkable evolution, and this growth is driven largely by the increasing need for digital transformation within businesses across various industries. As of recent evaluations, the market size is projected to expand to USD 79.30 billion, following a growth rate of...

Continue Reading